Where's it on?
FDA · Drugs ·

Trokendi XR, topiramate extended-release capsules recall

Supernus Pharmaceuticals, Inc. recalled Trokendi XR, topiramate extended-release capsules on July 29, 2026 because of failed dissolution specifications. It was sold nationwide.

Why it was recalled

Failed Dissolution Specifications

What's recalled

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Quantity: 15,853 bottles

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice